GlassScriptPhysician profile
Rodney A Short
NPI 1184602013
$5,703.67
in general payments reported to CMS, 2019-2025
51 companies · $1,195 in 2025
The $1,195 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $497 · 2020: $154 · 2021: $436 · 2022: $1,946 · 2023: $765 · 2024: $710 · 2025: $1,195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,670.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $2,450.53 | 2022-2025 | |
| Abbvie INC. | $310.59 | 2019-2025 | Duopa, Qulipta, Ubrelvy |
| Teva Pharmaceuticals USA, INC. | $286.39 | 2019-2025 | Austedo Xr, Austedo Xr |
| Lundbeck LLC | $233.37 | 2022-2025 | Vyepti, Rexulti |
| Lilly USA, LLC | $228.64 | 2019-2025 | Kisunla, Amyvid |
| Genentech USA, INC. | $212.84 | 2021-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Novartis Pharmaceuticals Corporation | $200.23 | 2019-2025 | |
| Amneal Pharmaceuticals LLC | $151.80 | 2019-2025 | Rytary, Crexont |
| Biogen, INC. | $130.64 | 2019-2024 | Vumerity, Tysabri, Plegridy |
| Emd Serono, INC. | $104.93 | 2019-2024 | |
| Otsuka America Pharmaceutical, INC. | $89.94 | 2023-2025 | Rexulti |
| Csl Behring | $78.34 | 2023-2025 | Hizentra |
| Mdd US Operations, LLC | $69.25 | 2019-2024 | Apokyn, Xadago, Myobloc |
| Kyowa Kirin, INC. | $67.51 | 2019-2023 | Nourianz |
| Celgene Corporation | $64.68 | 2023-2024 | Zeposia |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Short listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.